1. Home
  2. SPRO vs SKLZ Comparison

SPRO vs SKLZ Comparison

Compare SPRO & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • SKLZ
  • Stock Information
  • Founded
  • SPRO 2013
  • SKLZ 2012
  • Country
  • SPRO United States
  • SKLZ United States
  • Employees
  • SPRO N/A
  • SKLZ N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • SKLZ EDP Services
  • Sector
  • SPRO Health Care
  • SKLZ Technology
  • Exchange
  • SPRO Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • SPRO 121.0M
  • SKLZ 136.4M
  • IPO Year
  • SPRO 2017
  • SKLZ N/A
  • Fundamental
  • Price
  • SPRO $1.90
  • SKLZ $7.22
  • Analyst Decision
  • SPRO Buy
  • SKLZ Buy
  • Analyst Count
  • SPRO 4
  • SKLZ 1
  • Target Price
  • SPRO $5.00
  • SKLZ $14.00
  • AVG Volume (30 Days)
  • SPRO 323.5K
  • SKLZ 63.8K
  • Earning Date
  • SPRO 11-13-2025
  • SKLZ 11-06-2025
  • Dividend Yield
  • SPRO N/A
  • SKLZ N/A
  • EPS Growth
  • SPRO N/A
  • SKLZ N/A
  • EPS
  • SPRO N/A
  • SKLZ N/A
  • Revenue
  • SPRO $48,576,000.00
  • SKLZ $93,320,000.00
  • Revenue This Year
  • SPRO N/A
  • SKLZ $17.44
  • Revenue Next Year
  • SPRO N/A
  • SKLZ $12.03
  • P/E Ratio
  • SPRO N/A
  • SKLZ N/A
  • Revenue Growth
  • SPRO N/A
  • SKLZ N/A
  • 52 Week Low
  • SPRO $0.51
  • SKLZ $3.54
  • 52 Week High
  • SPRO $3.22
  • SKLZ $9.11
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 40.19
  • SKLZ 40.76
  • Support Level
  • SPRO $1.91
  • SKLZ $7.00
  • Resistance Level
  • SPRO $2.18
  • SKLZ $7.54
  • Average True Range (ATR)
  • SPRO 0.09
  • SKLZ 0.30
  • MACD
  • SPRO 0.00
  • SKLZ -0.12
  • Stochastic Oscillator
  • SPRO 11.94
  • SKLZ 11.17

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: